Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver. It designs short interfering RNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell. The company is developing various product candidates, including SLN360, which is Phase I clinical trials for the treatment of cardiovascular disease with high lipoprotein; SLN124 that is in Phase I clinical trials for the treatment of non-transfusion dependent thalassemia, and Phase I clinical trials for the treatment of myelodysplastic syndrome; and SLN124 for the treatment of polycythemia vera. It has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize small interfering RNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and Mallinckrodt Pharma IP Trading DAC to develop and commercialize RNAi drug targets designed to silence the complement cascade in complement-mediated disorders. The company also has a collaboration with Hansoh Pharmaceutical Group Company Limited to develop siRNAs for three undisclosed targets leveraging Silence's mRNAi GOLD platform. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Silence Therapeutics Plc American Depository Share.
Silence Therapeutics Plc American Depository Share business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Silence Therapeutics Plc American Depository Share are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Silence Therapeutics Plc American Depository Share , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Silence Therapeutics Plc American Depository Share including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Silence Therapeutics Plc American Depository Share and all latest updates of the company are provided.
The 2025 version of Silence Therapeutics Plc American Depository Share report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Silence Therapeutics Plc American Depository Share- Key Facts
2.2 Silence Therapeutics Plc American Depository Share- Geographic Locations
2.3 Silence Therapeutics Plc American Depository Share- Subsidiaries and Affiliates
2.4 Silence Therapeutics Plc American Depository Share- Business Divisions
2.5 Silence Therapeutics Plc American Depository Share- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Silence Therapeutics Plc American Depository Share Strategic Analysis Review
3.1 Silence Therapeutics Plc American Depository Share- Key Strategies
3.2 Silence Therapeutics Plc American Depository Share- Company Outlook Statement
3.3 Silence Therapeutics Plc American Depository Share- SWOT Analysis
3.3.1 Silence Therapeutics Plc American Depository Share- Key Strengths
3.3.2 Silence Therapeutics Plc American Depository Share- Key Weaknesses
3.3.3 Silence Therapeutics Plc American Depository Share- Potential Opportunities
3.3.4 Silence Therapeutics Plc American Depository Share- Potential Threats
3.4 Silence Therapeutics Plc American Depository Share- Key Competitors
4. Business Description of the Company
4.1 Silence Therapeutics Plc American Depository Share- Business Overview
4.2 Silence Therapeutics Plc American Depository Share- Operations by Segment
5 Products and Services Details
5.1 Silence Therapeutics Plc American Depository Share- Key Products
5.2 Silence Therapeutics Plc American Depository Share- Key Service Areas
5.3 Silence Therapeutics Plc American Depository Share- Key Brands
6 Company Developments
6.1 Silence Therapeutics Plc American Depository Share- Company History
6.2 Silence Therapeutics Plc American Depository Share- Latest Developments
7 Financial Analysis
7.1 Silence Therapeutics Plc American Depository Share- Income Statements
7.2 Silence Therapeutics Plc American Depository Share- Balance Sheet
7.3 Silence Therapeutics Plc American Depository Share- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Silence Therapeutics Plc American Depository Share- Direct Competitors
8.2 Silence Therapeutics Plc American Depository Share- Competitor Financial Ratios comparison
8.3 Silence Therapeutics Plc American Depository Share- Competitor Stock Charts Comparison
8.4 Silence Therapeutics Plc American Depository Share- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
